ArticleJournal of medical case reports2026
Systemic lupus erythematosus presenting with slurred speech: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSystemic lupus erythematosus is a chronic autoimmune disease with heterogeneous clinical manifestations. Neuropsychiatric involvement is relatively common in systemic lupus erythematosus; however, isolated dysarthria or slurred speech is an exceedingly rare presentation. Reporting such atypical manifestations may improve clinical awareness and facilitate early diagnosis of neuropsychiatric systemic lupus erythematosus. CASE PRESENTATION: A 14-year-old Iranian girl with no family history of autoimmune disease was referred to the rheumatology department with persistent fatigue, weakness, arthralgia, and progressive slurred speech, which significantly impaired her academic performance. Physical examination revealed malar rash, oral ulcers, alopecia, arthritis, and dysarthria. Laboratory evaluation demonstrated leukopenia, thrombocytopenia, hypocomplementemia (C3: 37 mg/dL, C4: 5.4 mg/dL), elevated erythrocyte sedimentation rate (132 mm/hour), positive antinuclear antibodies (1:1000), high anti-double-stranded DNA and anti-histone antibody levels, and positive antiphospholipid antibodies. Brain magnetic resonance imaging showed white matter hyperintensities in the centrum semiovale, suggestive of inflammatory or vasculitic involvement. The patient was treated with intravenous methylprednisolone followed by cyclophosphamide induction therapy and oral corticosteroids, resulting in marked clinical and laboratory improvement. Maintenance therapy with mycophenolate mofetil was initiated, and the patient remained clinically stable during follow-up.
conclusionThis case highlights isolated dysarthria as a rare but clinically significant manifestation of neuropsychiatric systemic lupus erythematosus. Awareness of such atypical neurological presentations may contribute to earlier recognition and appropriate management, leading to favorable long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.